Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Leiomyosarcoma × PTC596 × Clear all

Phase

Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Neoplasms 1 Leiomyosarcoma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

belinostat 2 Gemcitabine 2 Doxorubicin 2 selinexor 1 sargramostim 1 pembrolizumab 1 itacitinib 1 futibatinib 1 cixutumumab 1 baricitinib 1 avelumab 1 Trabectedin 1 Radiotherapy 1 PTC596 1 Ifosfamide 1 INCB039110 1 Fluorouracil 1 Erlotinib Hydrochloride 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03761095 2024-03-15

A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

PTC Therapeutics

Phase 1 Completed

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡